Systolic BP Variation Linked to Poor Outcomes

by U.S. Medicine

November 13, 2016

ALBANY, NY—Within individual patients, blood pressure (BP) fluctuates dynamically over time, and previous clinical studies have suggested an adverse link between greater visit-to-visit variability in systolic blood pressure (SBP) and various outcomes, according to a new study.

According to an article in the Journal of the American College of Cardiology, these studies have had significant limitations, however, such as a small size, inclusion of selected populations and restricted outcomes.1

In response, Albany, NY, Stratton VAMC-led researchers investigated the association of increased visit-to-visit variability with all-cause mortality, cardiovascular events and end-stage renal disease (ESRD) in a large cohort of U.S. veterans.

From among 3,285,684 veterans with and without hypertension and normal estimated glomerular filtration rates (eGFR) during 2005 and 2006, the study team identified 2,865,157 patients who had eight or more outpatient BP measurements.

Systolic blood pressure variability (SBPV) was measured using the SD of all SBP values (normally distributed) in one individual. Researchers examined associations of SD quartiles (<10.3, 10.3 to 12.7, 12.7 to 15.6, and ≥15.6mmHg) with all-cause mortality, incident coronary heart disease (CHD), stroke and ESRD, adjusting for sociodemographic characteristics, baseline eGFR, comorbidities, body mass index, SBP, diastolic BP and antihypertensive medication use.

Results indicate that higher intraindividual SBPV was associated with several sociodemographic variables and clinical characteristics:

  • Older age,
  • Male sex,
  • African-American race, and
  • Divorced or widowed status
  • Lower baseline eGFR,
  • Higher SBP and diastolic BP, and
  • Comorbidities, such as the presence of diabetes, hypertension, cardiovascular disease and lung disease.

“Higher SBPV in individuals with and without hypertension was associated with increased risks of all-cause mortality, CHD, stroke, and ESRD,” study authors concluded. “Further studies are needed to determine interventions that can lower SBPV and their impact on adverse health outcomes.”

1.    Gosmanova EO, Mikkelsen MK, Molnar MZ, Lu JL, Yessayan LT, Kalantar-Zadeh K, Kovesdy CP. Association of Systolic Blood Pressure Variability With Mortality, Coronary Heart Disease, Stroke, and Renal Disease. J Am Coll Cardiol. 2016 Sep 27;68(13):1375-86. doi: 10.1016/j.jacc.2016.06.054. PubMed PMID: 27659458.

Related Articles

RA Fracture Risk Affected by Glucocorticoid Treatment

How much does systemic glucocorticoid exposure increase fracture among patients with newly-diagnosed inflammatory and immune-modulated conditions, including rheumatoid arthritis.

Obesity, Weight-Loss Both Worsen RA U.S. Medicine

Obese patients with rheumatoid arthritis report greater disability in cross-sectional studies, but what that means over the long term has not been studied often.

U.S. Medicine Recommends

More From department of veterans affairs

Department of Veterans Affairs (VA)

VHA Makes Progress in Improving Safety of Opioid Prescribing

VHA medical facilities should ensure that its providers are following three key opioid risk mitigation strategies, including conducting urine drug screening, a recent report recommended.

Department of Veterans Affairs (VA)

VA faces healthcare staffing shortages, barriers to hiring facility leaders

A facility-specific survey found that 138 of 140 VA facilities reported shortages of medical officers, with psychiatry and primary care positions being the most frequently listed.

Department of Veterans Affairs (VA)

Veteran nephrologist labors to improve ESRD treatment at VA

When Terrence O’Neil, MD, retired as chief of nephrology at the James H. Quillen VAMC in Johnson City in December 2016, he left in his wake decades of work treating kidney disease—nearly 35 years in the Air Force and DoD, plus 11 more at VA.

Department of Veterans Affairs (VA)

Committee approves bill to provide agent orange benefits to ‘blue water’ vets

A long sought-after bill that would make it easier for Blue Water Navy veterans to receive Agent Orange benefits has been passed by a key House of Representatives committee.

Department of Veterans Affairs (VA)

Bill to Streamline, Expand VA’s Choice Program Signed Into Law

Legislation that would streamline VA’s community care programs into one program and expand VA’s caregiver program to veterans of all eras was signed into law earlier this month..

Facebook Comment

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up